Market Tracker

06/18 5:15pm ET

Haemonetics Corp (NYSE:HAE)

93.61
Delayed Data
As of 4:02pm ET
 +2.48 / +2.72%
Today’s Change
38.47
Today|||52-Week Range
96.84
+61.17%
Year-to-Date
Haemonetics' Plasma Momentum Solid, Margins Gain Traction
11:23am / Zacks.com - Paid Partner Content
Baxter (BAX) Soars to a 52-Week High, Time to Cash Out?
Jun 13 / Zacks.com - Paid Partner Content
Medical Device Industry Outlook - June 2018
Jun 14 / Zacks.com - Paid Partner Content
Why is Haemonetics (HAE) Up 15.6% Since Its Last Earnings Report?
Jun 07 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close91.13
Today’s open91.52
Day’s range91.17 - 93.83
Volume1,259,356
Average volume (3 months)612,017
Market cap$4.7B
Data as of 4:02pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+16.18%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+2.01%
P/E ratio110.1
Price/Sales4.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc+0.98+1.63%
MMSIMerit Medical System...+0.10+0.20%
INGNInogen Inc+6.41+3.49%
NXTMNxStage Medical Inc-0.08-0.28%
Data as of 4:02pm ET, 06/18/2018

Financials

Next reporting dateJuly 30, 2018
EPS forecast (this quarter)$0.42
Annual revenue (last year)$903.9M
Annual profit (last year)$45.6M
Net profit margin5.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Executive Vice President-
Global Operations
Neil Ryding
Corporate headquarters
Braintree, Massachusetts

Forecasts